Sivik Global Healthcare LLC Buys SPDR Biotech ETF, Anthem Inc, Universal Health Services Inc, Sells Seagen Inc, Medtronic PLC, Smith & Nephew PLC

• New Purchases: XBI, ANTM, UHS, PFE, ABBV, ZBH, CVS, BMY, ISRG, WST, CAH, GH, NTRA, SRPT, EW, CRSP, MRTX, BPMC,
• Added Positions: HUM, THC,
• Reduced Positions: UNH, SEM, HCA, JNJ, EHC, IQV, BAX, BSX, ABT, CRL, MOH, MCK, BMRN, BDX, LLY, GMED, DHR, HOLX, AVTR, TMO, CYH, LH, OPCH, ABC,
• Sold Out: SGEN, MDT, SNN, CTLT, MRK, CNC, BRKR, REGN, MRVI, DGX, TECH, GRFS, LHCG, ACHC,

For the details of Sivik Global Healthcare LLC's stock buys and sells, go to https://www.gurufocus.com/guru/sivik+global+healthcare+llc/current-portfolio/portfolio

1. SPDR Biotech ETF (XBI) - 100,000 shares, 4.80% of the total portfolio. New Position
2. UnitedHealth Group Inc (UNH) - 17,500 shares, 3.76% of the total portfolio. Shares reduced by 75%
3. McKesson Corp (MCK) - 35,000 shares, 3.73% of the total portfolio. Shares reduced by 22.22%
4. Thermo Fisher Scientific Inc (TMO) - 12,500 shares, 3.57% of the total portfolio. Shares reduced by 16.67%
5. Danaher Corp (DHR) - 25,000 shares, 3.52% of the total portfolio. Shares reduced by 16.67%

Sivik Global Healthcare LLC initiated holding in SPDR Biotech ETF. The purchase prices were between $108.77 and $134.15, with an estimated average price of $120.52. The stock is now traded at around $93.250000. The impact to a portfolio due to this purchase was 4.8%. The holding were 100,000 shares as of 2021-12-31.

Sivik Global Healthcare LLC initiated holding in Anthem Inc. The purchase prices were between $370.08 and $467.67, with an estimated average price of $421.99. The stock is now traded at around $449.430000. The impact to a portfolio due to this purchase was 3.48%. The holding were 17,500 shares as of 2021-12-31.

Sivik Global Healthcare LLC initiated holding in Universal Health Services Inc. The purchase prices were between $116.39 and $137.35, with an estimated average price of $128.38. The stock is now traded at around $127.210000. The impact to a portfolio due to this purchase was 3.33%. The holding were 60,000 shares as of 2021-12-31.

Sivik Global Healthcare LLC initiated holding in Pfizer Inc. The purchase prices were between $41.32 and $61.25, with an estimated average price of $49.81. The stock is now traded at around $53.210000. The impact to a portfolio due to this purchase was 2.53%. The holding were 100,000 shares as of 2021-12-31.

Sivik Global Healthcare LLC initiated holding in AbbVie Inc. The purchase prices were between $107.43 and $135.93, with an estimated average price of $118.5. The stock is now traded at around $142.530000. The impact to a portfolio due to this purchase was 2.32%. The holding were 40,000 shares as of 2021-12-31.

Sivik Global Healthcare LLC initiated holding in Zimmer Biomet Holdings Inc. The purchase prices were between $118.89 and $151.03, with an estimated average price of $134.39. The stock is now traded at around $111.670000. The impact to a portfolio due to this purchase was 2.31%. The holding were 42,500 shares as of 2021-12-31.

Sivik Global Healthcare LLC added to a holding in Humana Inc by 40.00%. The purchase prices were between $384.96 and $469.02, with an estimated average price of $443.48. The stock is now traded at around $430.350000. The impact to a portfolio due to this purchase was 0.99%. The holding were 17,500 shares as of 2021-12-31.

Sivik Global Healthcare LLC sold out a holding in Seagen Inc. The sale prices were between $142.57 and $190.86, with an estimated average price of $167.3.

Sivik Global Healthcare LLC sold out a holding in Medtronic PLC. The sale prices were between $99.53 and $127.75, with an estimated average price of $115.4.

Sivik Global Healthcare LLC sold out a holding in Smith & Nephew PLC. The sale prices were between $31.98 and $37.15, with an estimated average price of $34.32.

Sivik Global Healthcare LLC sold out a holding in Catalent Inc. The sale prices were between $119.57 and $139.07, with an estimated average price of $128.41.

Sivik Global Healthcare LLC sold out a holding in Merck & Co Inc. The sale prices were between $72.28 and $90.54, with an estimated average price of $79.6.

Sivik Global Healthcare LLC sold out a holding in Centene Corp. The sale prices were between $61.94 and $84.72, with an estimated average price of $73.64.